Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 4/20 | 0.59 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.58 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.54 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.54 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.54 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 3/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | GRIN2D | O15399 | 2/20 | 0.49 |
| ▸ | GRIN3B | O60391 | 2/20 | 0.49 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.49 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.49 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.49 |
| ▸ | GRIN2C | Q14957 | 2/20 | 0.49 |
| ▸ | GRIN3A | Q8TCU5 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15655473 | 1.00 | EPHX2 (0.59) | EPHX2EPHX1SIGMAR1TAS1R3TAS1R1 | |
| SCHEMBL15655475 | 1.00 | EPHX2 (0.59) | EPHX2EPHX1SIGMAR1TAS1R3TAS1R1 | |
| SCHEMBL26089624 | 1.00 | EPHX2 (0.59) | EPHX2EPHX1SIGMAR1TAS1R3TAS1R1 | |
| SCHEMBL15655476 | 1.00 | EPHX2 (0.59) | EPHX2EPHX1SIGMAR1TAS1R3TAS1R1 | |
| SCHEMBL3068813 | 0.84 | EPHX1 (0.76) | EPHX2EPHX1SIGMAR1TAS1R3TAS1R1 | |
| SCHEMBL3071717 | 0.84 | EPHX2 (0.61) | EPHX2EPHX1SIGMAR1TAS1R3TAS1R1 | |
| SCHEMBL23573482 | 0.83 | EPHX1 (0.54) | EPHX2EPHX1SIGMAR1TAS1R3TAS1R1 | |
| SCHEMBL7610644 | 0.81 | EPHX2 (0.58) | EPHX2EPHX1SIGMAR1TAS1R3TAS1R1 | |
| SCHEMBL5590888 | 0.81 | EPHX2 (0.58) | EPHX2EPHX1SIGMAR1TAS1R3TAS1R1 | |
| SCHEMBL19688352 | 0.81 | EPHX2 (0.58) | EPHX2EPHX1SIGMAR1TAS1R3TAS1R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11708320-B2 | Environmentally-friendly hydroazidation of olefins | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2023-07-25 | — | — | US | disclosed |
| WO-2023069708-A1 | COMPOUNDS THAT MEDIATE PROTEIN DEGRADATION AND USES THEREOF | MONTE ROSA THERAPEUTICS, INC. (US) | 2023-04-27 | — | — | WO | disclosed |
| US-20210284601-A1 | ENVIRONMENTALLY-FRIENDLY HYDROAZIDATION OF OLEFINS | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2021-09-16 | — | — | US | disclosed |
| EP-2968211-B1 | PHENYL ALKYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING EPILEPSY OR EPILEPSY-RELATED SYNDROME | BIO PHARM SOLUTIONS CO LTD (KR) | 2021-05-12 | — | — | EP | disclosed |
| EP-3784660-A1 | ENVIRONMENTALLY-FRIENDLY HYDROAZIDATION OF OLEFINS | Georgia State University Research Foundation, Inc. (US) | 2021-03-03 | — | — | EP | disclosed |
| EP-2797878-B1 | PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING STROKE | BIO-PHARM SOLUTIONS CO LTD (KR) | 2017-08-16 | — | — | EP | disclosed |
| US-7622526-B2 | Thermoset material based on antiplasticizing polythiourethane and ophthalmic lens comprising an antiplasticized thermoset material | ESSILOR INTERNATIONAL (FR) | 2009-11-24 | — | — | US | disclosed |
| US-20060270771-A1 | Thermoset material based on antiplasticizing polythiourethane and ophthalmic lens comprising an antiplasticized thermoset material | ESSILOR INTERNATIONAL COMPAGNIE GENERALE D'OPTIQUE (FR) | 2006-11-30 | — | — | US | disclosed |
| CN-1268679-A | Chemical enhancement type photoetching gum | NEC CORP (JP) | 2000-10-04 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11708320-B2 | Environmentally-friendly hydroazidation of olefins | HAO2, AHR, HMOX1 | EPHX2 876/4885EPHX1 314/4885SIGMAR1 1512/4885 |
| US-20210284601-A1 | ENVIRONMENTALLY-FRIENDLY HYDROAZIDATION OF OLEFINS | HAO2, AHR, HMOX1 | EPHX2 876/4885EPHX1 314/4885SIGMAR1 1512/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.